These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21628943)

  • 1. Improvement of rheumatoid arthritis and autoimmune hepatitis in a patient treated with the tumor necrosis factor inhibitor, etanercept.
    Umekita K; Miyauchi S; Ueno S; Takajo I; Kusumoto K; Hasuike S; Umekita Y; Tanaka H; Nagata K; Nagatomo Y; Kataoka H; Shimoda K; Okayama A
    Intern Med; 2011; 50(11):1245-9. PubMed ID: 21628943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with etanercept of autoimmune hepatitis associated with rheumatoid arthritis: an open label proof of concept study.
    Toulemonde G; Scoazec JY; Miossec P
    Ann Rheum Dis; 2012 Aug; 71(8):1423-4. PubMed ID: 22402143
    [No Abstract]   [Full Text] [Related]  

  • 3. Periodontitis and etanercept discontinuation risk in anti-tumor necrosis factor-naive rheumatoid arthritis patients: a nationwide population-based cohort study.
    Chen HH; Chen DY; Lai KL; Chen YM; Chou YJ; Chou P; Lin CH; Huang N
    J Clin Rheumatol; 2013 Dec; 19(8):432-8. PubMed ID: 24263145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients.
    Ballanti E; Conigliaro P; Chimenti MS; Kroegler B; Di Muzio G; Guarino MD; Triggianese P; Gigliucci G; Novelli L; Barbato C; Perricone R
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S42-5. PubMed ID: 25381975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
    Machado DA; Guzman RM; Xavier RM; Simon JA; Mele L; Pedersen R; Ferdousi T; Koenig AS; Kotak S; Vlahos B
    J Clin Rheumatol; 2014 Jan; 20(1):25-33. PubMed ID: 24356474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis.
    Spadaro A; Scrivo R; Riccieri V; Valesini G
    Joint Bone Spine; 2008 Jan; 75(1):87-9. PubMed ID: 17890133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creutzfeldt-Jakob disease in a patient treated by etanercept for rheumatoid arthritis (RA): just a coincidence?
    Soubrier M; Haïk S; Hauw JJ; Corvol JC; Lyon-Caen O; Dougados M
    Joint Bone Spine; 2010 Mar; 77(2):174-5. PubMed ID: 20097590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
    Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept normalises left ventricular mass in patients with rheumatoid arthritis.
    Daïen CI; Fesler P; du Cailar G; Daïen V; Mura T; Dupuy AM; Cristol JP; Ribstein J; Combe B; Morel J
    Ann Rheum Dis; 2013 Jun; 72(6):881-7. PubMed ID: 22872022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection.
    Peterson JR; Hsu FC; Simkin PA; Wener MH
    Ann Rheum Dis; 2003 Nov; 62(11):1078-82. PubMed ID: 14583571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stable remission of early active rheumatoid arthritis treated with etanercept (Enbrel)].
    Kaliterna DM
    Reumatizam; 2008; 55(2):60-1. PubMed ID: 19024277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.
    Williams VL; Cohen PR
    Int J Dermatol; 2011 May; 50(5):619-25. PubMed ID: 21506984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of rheumatoid arthritis by TNF-blocking agents.
    Graninger W; Smolen J
    Int Arch Allergy Immunol; 2002 Jan; 127(1):10-4. PubMed ID: 11893849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etanercept treatment of rheumatoid arthritis in the "real world".
    Smith MD
    Ann Rheum Dis; 2003 Jan; 62(1):95-6; author reply 96. PubMed ID: 12480688
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-TNF agents for rheumatoid arthritis.
    Seymour HE; Worsley A; Smith JM; Thomas SH
    Br J Clin Pharmacol; 2001 Mar; 51(3):201-8. PubMed ID: 11298065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
    Ørnbjerg LM; Østergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Schlemmer A; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Bøhme W; Hansen A; Andersen AR; Hetland ML
    J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies].
    González-Gay MA; Agudo M
    Med Clin (Barc); 2010 May; 134(15):684-5. PubMed ID: 20176386
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor.
    Origuchi T; Iwamoto N; Kawashiri SY; Fujikawa K; Aramaki T; Tamai M; Arima K; Nakamura H; Yamasaki S; Ida H; Kawakami A; Ueki Y; Matsuoka N; Nakashima M; Mizokami A; Kawabe Y; Mine M; Fukuda T; Eguchi K
    Mod Rheumatol; 2011 Jun; 21(3):244-50. PubMed ID: 21188454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which TNF inhibitor for rheumatoid arthritis?
    Med Lett Drugs Ther; 2010 May; 52(1338):38-9. PubMed ID: 20467356
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
    Cacciapaglia F; Anelli MG; Rinaldi A; Serafino L; Covelli M; Scioscia C; Iannone F; Lapadula G
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S77-80. PubMed ID: 25381986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.